FindTrial
Sign In

To assess and compare the post- operative analgesic effect of wound infiltration with bupivacaine versus mixture of bupivacaine and tramadol undergoing caesarean section under spinal anaesthesia.

Post Operative Analgesic Effect of Wound infiltration with Bupivacaine versus mixture of Bupivacaine and Tramadol in Caesarean Section under Spinal anaesthesia: A Randomized, Double Blind, Interventional Study at S.M.S. Medical College and Attached Hospitals, Jaipur during year 2020-22.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031140
Enrollment
60
Registered
2021-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: injection Bupivacaine 0.25%: Subcutaneous infiltration by injection Bupivacaine 0.25% at incision site(total dose 20 ml) Control Intervention1: injection Bupivacaine 0.25% mixed with tr

Sponsors

Department of Anesthesiology Sawai Man Singh Medical College And Attached Hospitals Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients undergoing caesarean section under spinal anesthesia. 2.Patients willing to give written informed consent. 3.Age 18 to 35 years. 4.Height 145 to 165 cm. 5.Weight from 40 to 70 kg. 6.Patients with ASA grade I and II.

Exclusion criteria

Exclusion criteria: 1.Patients not willing to participate in the study. 2.Uncooperative patients. 3.Immuno-compromise patients. 4.Patients with severe cardiopulmonary, renal or liver disease, pre- eclampsia, eclampsia, morbidly obese, bleeding or coagulation disorders. 5. Patients allergic to drugs used in study. 6. Cases with sepsis, bacteremia or skin infection of local site.

Design outcomes

Primary

MeasureTime frame
To determine the difference between mean time for need of first rescue analgesic in both groups.Timepoint: 24 hours—

Secondary

MeasureTime frame
1.Difference in change in hemodynamic variable from baseline to postoperative period in both groups. 2.Difference in percentage of patients who develop side effects in both groups. Timepoint: 24 hours—

Countries

India

Contacts

Public ContactDR MAHESH KUMAR

S.M.S. Medical College Jaipur

trishala.jain31@gmail.com9414281744

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026